Literature DB >> 20814731

3β-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression.

Gleice da Graça Rocha1, Marisol Simões, Rodrigo Rodrigues Oliveira, Maria Auxiliadora Coelho Kaplan, Cerli Rocha Gattass.   

Abstract

Chronic myeloid leukemia (CML) is a potentially fatal stem-cell cancer. P-glycoprotein (P-gp/ABCB1) activity has been described as a relevant factor in the chemotherapeutic failure and correlated to a poor prognosis in these malignancies. In the present study, we investigated the mechanism of the antineoplastic activity of 3β-acetyl tormentic acid (3ATA), a triterpene isolated from C. lyratiloba, on Lucena-1, an MDR leukemia cell line, that overexpressed P-gp/ABCB1. Results showing that this triterpene induced DNA-fragmentation, activation of caspase-3 and cytochrome c release indicated that its activity is mediated by the activation of the intrinsic pathway of apoptosis. Interestingly, this triterpene did not interfere with P-gp/ABCB1 expression or activity, indicating that induction of death is not mediated by any effect on this protein. Moreover, the results show that none of the others triterpenes from C. lyratiloba were able to modulate the activity of P-gp/ABCB1. Together these results suggest 3ATA and the other triterpenes as a promising material for the development of anti-neoplastic drugs for leukemia and other tumors independent of P-gp/ABCB1 activity or expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814731     DOI: 10.1007/s10637-010-9524-1

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  38 in total

1.  MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia.

Authors:  Zineb Benderra; Anne Marie Faussat; Lydia Sayada; Jean-Yves Perrot; Ruoping Tang; Driss Chaoui; Hamid Morjani; Christophe Marzac; Jean-Pierre Marie; Ollivier Legrand
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

2.  Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Authors:  C P Leith; K J Kopecky; I M Chen; L Eijdems; M L Slovak; T S McConnell; D R Head; J Weick; M R Grever; F R Appelbaum; C L Willman
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

Review 3.  Important therapeutic targets in chronic myelogenous leukemia.

Authors:  Hagop M Kantarjian; Francis Giles; Alfonso Quintás-Cardama; Jorge Cortes
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

Review 4.  Pharmacological strategies for overcoming multidrug resistance.

Authors:  S Nobili; I Landini; B Giglioni; E Mini
Journal:  Curr Drug Targets       Date:  2006-07       Impact factor: 3.465

Review 5.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

6.  Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

Authors:  R Tang; A-M Faussat; P Majdak; J-Y Perrot; D Chaoui; O Legrand; J-P Marie
Journal:  Leukemia       Date:  2004-07       Impact factor: 11.528

Review 7.  The role of interferon-alpha in the treatment of chronic myeloid leukemia.

Authors:  Lisa A Kujawski; Moshe Talpaz
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-20       Impact factor: 7.638

8.  P-glycoprotein (P-170) expression in acute leukemias.

Authors:  Hasan A Abd El-Ghaffar; Doaa A Aladle; Sami E Farahat; Naglaa Abd El-Hady
Journal:  Hematology       Date:  2006-02       Impact factor: 2.269

Review 9.  State-of-the-art in the treatment of chronic myeloid leukaemia.

Authors:  Dragana Milojkovic; Jane Apperley
Journal:  Curr Opin Oncol       Date:  2008-01       Impact factor: 3.645

Review 10.  The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies.

Authors:  Dao M Nguyen; Mustafa Hussain
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

View more
  5 in total

1.  Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo.

Authors:  Kelly Araújo Lúcio; Gleice da Graça Rocha; Leonardo Campos Monção-Ribeiro; Janaina Fernandes; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

2.  A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line.

Authors:  Stephany Corrêa; Luciana Pizzatti; Bárbara Du Rocher; André Mencalha; Daniela Pinto; Eliana Abdelhay
Journal:  Proteome Sci       Date:  2012-03-30       Impact factor: 2.480

3.  Selection of chemical markers for the quality control of medicinal plants of the genus Cecropia.

Authors:  Andrés Rivera-Mondragón; Orlando O Ortíz; Sebastiaan Bijttebier; Arnold Vlietinck; Sandra Apers; Luc Pieters; Catherina Caballero-George
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  The Occurrence and Biological Activity of Tormentic Acid-A Review.

Authors:  Marta Olech; Wojciech Ziemichód; Natalia Nowacka-Jechalke
Journal:  Molecules       Date:  2021-06-22       Impact factor: 4.411

5.  Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity.

Authors:  Gleice Da Graça Rocha; Marisol Simões; Rodrigo Rodrigues Oliveira; Maria Auxiliadora Coelho Kaplan; Cerli Rocha Gattass
Journal:  Int J Mol Sci       Date:  2012-06-04       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.